Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02410798 · ClinicalTrials.gov registry record · NA
Clinical Study to Investigate Safety and Performance of TransLoc Electrodes in Patients Undergoing Surgical Procedures
A NA study, sponsored by Synapse Biomedical.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT02410798 is a NA study that has completed, run by Synapse Biomedical. The registered enrollment target is 12 participants.
The verdict
NCT02410798, a NA study, has completed, sponsored by Synapse Biomedical.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Feasibility study to advance the development of NeuRx Diaphragm Pacing System (DPS) for the intended use of stimulating the diaphragm to provide respiratory assistance in patients at risk of prolonged mechanical ventilation in the Intensive Care Unit (ICU).
Interventions
- DEVICE TransLoc electrode
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2015-05 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02410798
The ClinicalTrials.gov registry entry for NCT02410798 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Synapse Biomedical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TransLoc electrode is the first listed.
NCT02410798 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02410798 about?
NCT02410798 is a clinical study titled "Clinical Study to Investigate Safety and Performance of TransLoc Electrodes in Patients Undergoing Surgical Procedures". Feasibility study to advance the development of NeuRx Diaphragm Pacing System (DPS) for the intended use of stimulating the diaphragm to provide respiratory assistance in patients at risk of prolonged mechanical ventilation in the Intensive Care Unit (ICU).
What is the current status of trial NCT02410798?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2015-05. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02410798?
The interventions under investigation include: TransLoc electrode (DEVICE).
Who is sponsoring clinical trial NCT02410798?
This trial is sponsored by Synapse Biomedical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.